advertising
-
1.
Goldblum JR & Fletcher JA: “Desmoid-Type Fibromatosis,“ in WHO Classification of Tumours of Soft Tissue and Bone, Vol 4 , ed by Fletcher CDM , Hogendoorn PCW & Mertens F et al, p 72, International Agency for Research on Cancer, Lyon, 2013.
-
2.
MacFarlane J : Clinical Reports of the Surgical Practice of Glasgow Royal Infirmary , p 63, Robertson, Glasgow, 1832.
-
3.
Müller J: “Von der sehnigen Fasergeschwulst, Tumor fibrosus s. Desmoides,“ in Über den feinern Bau und die Formen der krankhaften Geschwülste, Volume Erste Lieferung, p 60, G. Reimer, Berlin, 1838.
-
4.
Reitamo JJ , Hayry P & Nykyri E et al.: The desmoid tumor: I. Incidence, sex-, age- and anatomical distribution in the Finnish population. Am J Clin Pathol 77 : 66, 1982.
-
5.
van Broekhoven DL , Grunhagen DJ & den Bakker MA et al.: Time trends in the incidence and treatment of extra-abdominal and abdominal aggressive fibromatosis: a population-based study. Ann Surg Oncol 22 : 2817, 2015.
-
6.
Sinha A , Tekkis PP & Gibbons DC et al.: Risk factors predicting desmoid occurrence in patients with familial adenomatous polyposis: a meta-analysis. Colorectal Dis 13 : 1222, 2011.
-
7.
Kulaylat MN , Karakousis CP & Keaney CM et al.: Desmoid tumour: a pleomorphic lesion. Eur J Surg Oncol 25 : 487, 1999.
-
8.
Eastley N , McCulloch T & Esler C et al.: Extra-abdominal desmoid fibromatosis: a review of management, current guidance and unanswered questions. Eur J Surg Oncol 42 : 1071, 2016.
-
9.
Merchant NB , Lewis JJ & Woodruff JM et al.: Extremity and trunk desmoid tumors: a multifactorial analysis of outcome. Cancer 86 : 2045, 1999.
-
10.
Wagstaff MJ , Raurell A & Perks AG: Multicentric extra-abdominal desmoid tumours. Br J Plast Surg 57 : 362, 2004.
-
11.
Mankin HJ , Hornicek FJ & Springfield DS: Extra-abdominal desmoid tumors: a report of 234 cases. J Surg Oncol 102 : 380, 2010.
-
12.
Janinis J , Patriki M & Vini L et al.: The pharmacological treatment of aggressive fibromatosis: a systematic review. Ann Oncol 14 : 181, 2003.
-
13.
Wirth L , Klein A & Baur-Melnyk A et al.: Desmoid tumours of the extremity and trunk: a retrospective study of 44 patients. BMC Musculoskelet Disord 19 : 2, 2018.
-
14.
Alexander IJ , Johnson KA & Shives TC et al.: Aggressive fibromatosis of the plantar aspect of the foot: a case report. Bull Hosp Jt Dis Orthop Inst 47 : 103, 1987.
-
15.
Barbella R & Fox IM: Recurring desmoid tumor of the foot: a case study. Foot Ankle Int 17 : 221, 1996.
-
16.
Macgill AA , Milione VR & Sullivan LG: Extra-abdominal desmoid fibromatosis in the foot: a case study. JAPMA 101 : 70, 2011.
-
17.
Saleem O , Sayres S & O'Malley M: Extra-abdominal periosteal desmoid tumor of the third toe. Orthopedics 36 : e1209, 2013.
-
18.
Kasper B , Baumgarten C & Bonvalot S et al.; Desmoid Working Group: Management of sporadic desmoid-type fibromatosis: a European consensus approach based on patients' and professionals' expertise: a sarcoma patients EuroNet and European Organisation for Research and Treatment of Cancer/Soft Tissue and Bone Sarcoma Group initiative. Eur J Cancer 51 : 127, 2015.
-
19.
Kamali F , Wang WL & Guadagnolo BA et al.: MRI may be used as a prognostic indicator in patients with extra-abdominal desmoid tumours. Br J Radiol 89 : 20150308, 2016.
-
20.
Koba T , Susa M & Nakayama R et al.: Desmoplastic fibroma arising in the distal phalanx of the great toe: a case report. J Foot Ankle Surg 53 : 71, 2014.
-
21.
Kim OH , Kim SJ & Kim JY et al.: Desmoplastic fibroma of bone in a toe: radiographic and MRI findings. Korean J Radiol 14 : 963, 2013.
-
22.
Dürr HR , Krödel A & Trouillier H et al.: Fibromatosis of the plantar fascia: diagnosis and indications for surgical treatment. Foot Ankle Int 20 : 13, 1999.
-
23.
Shin SH , Ko KR & Cho SK et al.: Surgical outcome of desmoid tumors: adjuvant radiotherapy delayed the recurrence, but did not affect long-term outcomes. J Surg Oncol 108 : 28, 2013.
-
24.
Chew C , Reid R & O'Dwyer PJ: Evaluation of the long term outcome of patients with extremity desmoids. Eur J Surg Oncol 30 : 428, 2004.
-
25.
Peng PD , Hyder O & Mavros MN et al.: Management and recurrence patterns of desmoids tumors: a multi-institutional analysis of 211 patients. Ann Surg Oncol 19 : 4036, 2012.
-
26.
Eastley N , Aujla R & Silk R et al.: Extra-abdominal desmoid fibromatosis: a sarcoma unit review of practice, long term recurrence rates and survival. Eur J Surg Oncol 40 : 1125, 2014.
-
27.
Shido Y , Nishida Y & Nakashima H et al.: Surgical treatment for local control of extremity and trunk desmoid tumors. Arch Orthop Trauma Surg 129 : 929, 2009.
-
28.
Pritchard DJ , Nascimento AG & Petersen IA: Local control of extra-abdominal desmoid tumors. J Bone Joint Surg Am 78 : 848, 1996.
-
29.
Leithner A , Gapp M & Leithner K et al.: Margins in extra-abdominal desmoid tumors: a comparative analysis. J Surg Oncol 86 : 152, 2004.
-
30.
Melis M , Zager JS & Sondak VK: Multimodality management of desmoid tumors: how important is a negative surgical margin? J Surg Oncol 98 : 594, 2008.
-
31.
Gronchi A , Casali PG & Mariani L et al.: Quality of surgery and outcome in extra-abdominal aggressive fibromatosis: a series of patients surgically treated at a single institution. J Clin Oncol 21 : 1390, 2003.
-
32.
Ballo MT , Zagars GK & Pollack A: Radiation therapy in the management of desmoid tumors. Int J Radiat Oncol Biol Phys 42 : 1007, 1998.
-
33.
Baumert BG , Spahr MO & Von Hochstetter A et al.: The impact of radiotherapy in the treatment of desmoid tumours: an international survey of 110 patients: a study of the Rare Cancer Network. Radiat Oncol 2 : 12, 2007.
-
34.
Ballo MT , Zagars GK & Pollack A et al.: Desmoid tumor: prognostic factors and outcome after surgery, radiation therapy, or combined surgery and radiation therapy. J Clin Oncol 17 : 158, 1999.
-
35.
Spear MA , Jennings LC & Mankin HJ et al.: Individualizing management of aggressive fibromatoses. Int J Radiat Oncol Biol Phys 40 : 637, 1998.
-
36.
Lev D , Kotilingam D & Wei C et al.: Optimizing treatment of desmoid tumors. J Clin Oncol 25 : 1785, 2007.
-
37.
Quast DR , Schneider R & Burdzik E et al.: Long-term outcome of sporadic and FAP-associated desmoid tumors treated with high-dose selective estrogen receptor modulators and sulindac: a single-center long-term observational study in 134 patients. Fam Cancer 15 : 31, 2016.
-
38.
Penel N , Le Cesne A & Bui BN et al.: Imatinib for progressive and recurrent aggressive fibromatosis (desmoid tumors): an FNCLCC/French Sarcoma Group phase II trial with a long-term follow-up. Ann Oncol 22 : 452, 2011.
-
39.
Briand S , Barbier O & Biau D et al.: Wait-and-see policy as a first-line management for extra-abdominal desmoid tumors. J Bone Joint Surg Am 96 : 631, 2014.
-
40.
Park JS , Nakache YP & Katz J et al.: Conservative management of desmoid tumors is safe and effective. J Surg Res 205 : 115, 2016.
-
41.
van Broekhoven DL , Grunhagenl DJ & van Dalen T et al.: Tailored beta-catenin mutational approach in extra-abdominal sporadic desmoid tumor patients without therapeutic intervention. BMC Cancer 16 : 686, 2016.
Desmoid Tumors of the Foot: A Retrospective Study of Four Patients
Search for other papers by Hans R. Dürr in
Current site
Google Scholar
PubMed
Search for other papers by Laura Wirth in
Current site
Google Scholar
PubMed
Search for other papers by Andrea Baur-Melnyk in
Current site
Google Scholar
PubMed
Search for other papers by Thomas Knösel in
Current site
Google Scholar
PubMed
Search for other papers by Falk Roeder in
Current site
Google Scholar
PubMed
Search for other papers by Volkmar Jansson in
Current site
Google Scholar
PubMed
Search for other papers by Alexander Klein in
Current site
Google Scholar
PubMed
Background
Desmoid-type fibromatosis (DF) is an aggressive (myo)fibroblastic neoplasm with an infiltrative growth pattern and a tendency for local recurrence. It is rarely seen at the foot. The aim of this retrospective study was to analyze clinical presentation, therapy, and outcomes in a consecutive series of four patients with DF at the foot.
Methods
From 1994 to 2014, four patients had been surgically treated. The resection margin was marginal or even intralesional in all. One patient already had local recurrence at first presentation. The end point was either local recurrence or progression of residual disease.
Results
The mean patient age was 27 years. In one patient, marginal excision healed the disease. In another patient, local recurrence after marginal resection necessitated distal phalanx amputation. Two other patients showed stable disease after either adjuvant radiotherapy or treatment with nonsteroidal anti-inflammatory drugs and tamoxifen.
Conclusions
If surgery is necessary, operative margins are less important than keeping function for the patient. Radiotherapy might be an option to avoid major amputation. The role of adjuvant radiotherapy is controversially discussed. A watchful wait-and-see policy seems to be justified by the published data but may be difficult for DF at the foot.
Musculoskeletal Oncology, Department of Orthopaedic Surgery, Physical Medicine, and Rehabilitation, University Hospital, Ludwig-Maximilians-University Munich, Munich, Germany.
Institute of Radiology, University Hospital, Ludwig-Maximilians-University Munich, Munich, Germany.
Institute of Pathology, University Hospital, Ludwig-Maximilians-University Munich, Munich, Germany.
Department of Radiation Oncology, University Hospital, Ludwig-Maximilians-University Munich, Munich, Germany.
advertising
advertising
